Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemia.

Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemia.

Item
http://www.wikidata.org/entity/Q33343818
Phase I trial of bortezomib (PS-341; NSC 681239) and alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory B-cell neoplasms.How I treat plasma cell leukemia.Phase I trial of bortezomib (PS-341; NSC 681239) and "nonhybrid" (bolus) infusion schedule of alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory indolent B-cell neoplasms.Plasma cell leukaemia and other aggressive plasma cell malignancies.Trends in survival of patients with primary plasma cell leukemia: a population-based analysis.Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research.Plasma cell leukemia: concepts and management.Plasma cell leukemia: from biology to treatment.Primary Plasma Cell Leukemia: Identity Card 2016.Therapeutic effect of bortezomib for primary plasma cell leukemia followed by auto/allo stem cell transplantationUse of a biventricular assist device in the treatment of acute doxorubicin-induced cardiotoxicity.Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients.Primary plasma cell leukemia: a retrospective multicenter study of 73 patients.
P2860

Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemia.

Item
http://www.wikidata.org/entity/Q33343818
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Intermediate doses of melphala ...... primary plasma cell leukemia.
@ast
Intermediate doses of melphala ...... primary plasma cell leukemia.
@en
type
label
Intermediate doses of melphala ...... primary plasma cell leukemia.
@ast
Intermediate doses of melphala ...... primary plasma cell leukemia.
@en
prefLabel
Intermediate doses of melphala ...... primary plasma cell leukemia.
@ast
Intermediate doses of melphala ...... primary plasma cell leukemia.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Intermediate doses of melphala ...... primary plasma cell leukemia.
@en
P2093
P304
P31
P356
P433
P478
P577
P698
P921